Analysts have nudged their price target for NHN higher to ₩33,533 from ₩33,225, citing refined assumptions around the discount rate, revenue, profit margin, and future P/E that slightly lift their fair value view.
What's in the News
- NHN completed a share repurchase program between October 23, 2025 and December 8, 2025, buying back 420,562 shares, equal to 1.35% of its shares, for a total of ₩12,831.39 million (Key Developments).
Valuation Changes
- Fair Value: The price target fair value has risen slightly from ₩33,225 to about ₩33,533 per share.
- Discount Rate: The discount rate assumption has fallen slightly from 9.85% to about 9.75%.
- Revenue Growth: The revenue growth assumption has eased slightly from about 8.05% to about 7.95%.
- Net Profit Margin: The net profit margin assumption has risen marginally from about 5.18% to about 5.20%.
- Future P/E: The future P/E multiple used in the model has risen slightly from about 7.89x to about 7.95x.
Have other thoughts on NHN?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.